IP Library Granted Patent US 8,822,219
Granted Patent B2
US 8,822,219 · App. 13/154,851 · Granted Sep 2, 2014

Method for preparing biological tissues for use in biological prostheses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,822,219
App. No.
13/154,851
Granted
Sep 2, 2014
Kind
B2
Abstract

A method of treating a biological tissue for biological prostheses includes steps of fixation of the biological tissue via a fixing solution including glutaraldehyde and detoxification of the fixed biological tissue via treatment with a detoxifying solution. The detoxification step includes one or both of eliminating phospholipids via treatment with an elimination solution and a treatment with a detoxifying solution. The elimination solution includes 1,2-octanediol and ethanol. The detoxifying solution includes taurine or homocysteic acid.

Claims (15)

1. A method of treating a biological tissue for use in a biological prosthesis, the method comprising the steps:

eliminating phospholipids from the biological tissue via treatment with an elimination solution including 5% v/v 1,2-octanediol and 40% v/v ethanol at a pH of 7.2 and a temperature of 37° C.;

fixing the biological tissue via a treatment with a fixing solution containing 0.5% v/v glutaraldehyde in phosphate buffer at a pH of 7.4; and

detoxifying the fixed biological tissue via treatment with a detoxifying solution including taurine or homocysteic acid in phosphate buffer at pH 7 and at a temperature above room temperature.

2. The method according to claim 1 , wherein detoxification occurs at a temperature above 30° C.

3. The method according to claim 1 , wherein elimination of phospholipids is carried out for a time period in the range of 2 to 7 days.

4. The method according to claim 1 , wherein elimination of phospholipids is carried out for a time period in the range of 16 to 72 hours.

5. The method according to claim 1 , wherein the detoxifying solution includes taurine at a concentration expressed as w/v in the range from 0.10% to saturation.

6. The method according to claim 1 , wherein the detoxifying solution includes taurine at a concentration expressed as w/v in the range of 0.20% to 1.00%.

7. The method according to claim 1 , wherein the detoxifying solution includes homocysteic acid at a concentration expressed as w/v in the range from 0.10% to saturation.

8. The method according to claim 1 , wherein the detoxifying solution includes homocysteic acid at a concentration expressed as w/v in the range of 0.50% to 5.00%.

9. The method according to claim 1 , wherein the detoxification step is carried out at a temperature greater than 30° C.

10. The method according to claim 1 , wherein the detoxification step is carried out at a temperature between 35° C. and 45° C.

11. The method according to claim 1 , wherein the detoxification step is carried out for a period in the range of 2 to 36 hours.

12. The method according to claim 1 , wherein the detoxification step is carried out for a period of 12 to 48 hours.

Assignments (4)
SECURITY INTEREST Recorded Jun 22, 2022
From: CORCYM S.R.L.
To: HAYFIN SERVICES LLP
Reel/Frame 060451/0783 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2021
From: SORIN GROUP ITALIA S.R.L.
To: CORCYM S.R.L.
Reel/Frame 056543/0862 →
MERGER Recorded Jul 28, 2014
From: SORIN BIOMEDICA CARDIO S.R.L.
To: SORIN GROUP ITALIA S.R.L.
Reel/Frame 033402/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2011
From: STRASLY, MARINA; ROLANDO, GIOVANNI
To: SORIN BIOMEDICA CARDIO S.R.L.
Reel/Frame 026795/0620 →